Philip Ashton-Rickardt
Direttore Tecnico/Scientifico/R&S presso SIGILON THERAPEUTICS, INC.
Patrimonio netto: - $ in data 31/07/2023
Posizioni attive di Philip Ashton-Rickardt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SIGILON THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 14/06/2021 | - |
Storia della carriera di Philip Ashton-Rickardt
Precedenti posizioni note di Philip Ashton-Rickardt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
AZTherapies, Inc.
 AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/01/2019 | 01/06/2021 |
Smith Therapeutics, Inc.
 Smith Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Smith Therapeutics, Inc. operates as a biopharmaceutical firm which treats neurodegenerative disease. The company was founded by Philip Ashton-Rickardt in 2017 and is headquartered in Chestnut, MA. | Direttore/Membro del Consiglio | 01/01/2017 | 31/10/2019 |
| Amministratore Delegato | 01/01/2017 | 31/10/2019 | |
| Fondatore | 01/01/2017 | 31/10/2019 | |
| Presidente | 01/01/2017 | 31/10/2019 | |
| Segretario Aziendale | 01/01/2017 | 31/10/2019 | |
| The University of Chicago | Corporate Officer/Principal | 01/06/1995 | 01/06/2006 |
| Imperial College London | Corporate Officer/Principal | - | - |
Formazione di Philip Ashton-Rickardt
| King's College London | Undergraduate Degree |
| The University of Edinburgh | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Regno Unito | 4 |
Posizioni
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Settori
| Consumer Services | 5 |
| Health Technology | 4 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SIGILON THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Smith Therapeutics, Inc.
Smith Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Smith Therapeutics, Inc. operates as a biopharmaceutical firm which treats neurodegenerative disease. The company was founded by Philip Ashton-Rickardt in 2017 and is headquartered in Chestnut, MA. | Health Technology |
AZTherapies, Inc.
AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Health Technology |
